Malignancy in pregnancy: Multimodality imaging and treatment.
cancer
computed tomography
immunotherapy
magnetic resonance imaging
malignancy
pregnancy
ultrasound
Journal
Cancer
ISSN: 1097-0142
Titre abrégé: Cancer
Pays: United States
ID NLM: 0374236
Informations de publication
Date de publication:
15 05 2023
15 05 2023
Historique:
revised:
25
07
2022
received:
30
04
2022
accepted:
30
08
2022
medline:
25
4
2023
pubmed:
14
3
2023
entrez:
13
3
2023
Statut:
ppublish
Résumé
The diagnosis of cancer is increasingly made in the pregnant population, thought to be from the increasing average age of pregnancy and the use of prenatal fetal noninvasive screening techniques, leading to incidental detection of cancer in the mother. Complex challenges are associated with imaging, diagnosis, staging, and treatment of cancers in this patient population, which require highly specialized interdisciplinary management. This report discusses the use of multimodality imaging and safety considerations in pregnant patients, reviews the current guidelines for ionizing radiation imaging techniques, and presents a series of commonly and uncommonly encountered cancers in pregnancy with current diagnostic imaging guidelines. The authors also discuss the role of multidisciplinary management and treatment options and provide an overview of therapy-related considerations in the age of novel anticancer therapies. PLAIN LANGUAGE SUMMARY: The diagnosis and management of pregnant patients who have cancer are actively evolving as novel imaging techniques and anticancer therapies are being developed. Radiologically, there are inherent difficulties in balancing the minimization of fetal ionization while acquiring diagnostic quality imaging necessary for the diagnosis, staging, and treatment of maternal disease. Standardized imaging protocols are still being developed, with evolving imaging guidelines coupled with rapidly expanding research and development of novel anticancer therapies, which come with their side effects and complications. Caring for this patient population is especially challenging and requires specialized multidisciplinary attention.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1479-1491Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2023 American Cancer Society.
Références
de Haan J, Verheecke M, Van Calsteren K, et al. Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients. Lancet Oncol. 2018;19(3):337-346. doi:10.1016/s1470-2045(18)30059-7
Vandecaveye V, Amant F, Lecouvet F, Van Calsteren K, Dresen RC. Imaging modalities in pregnant cancer patients. Int J Gynecol Cancer. 2021;31(3):423-431. doi:10.1136/ijgc-2020-001779
Silverstein J, Post AL, Chien AJ, et al. Multidisciplinary management of cancer during pregnancy. JCO Oncol Pract. 2020;16(9):545-557. doi:10.1200/op.20.00077
Parazzini F, Franchi M, Tavani A, Negri E, Peccatori FA. Frequency of pregnancy related cancer: a population based linkage study in Lombardy, Italy. Int J Gynecol Cancer. 2017;27(3):613-619. doi:10.1097/igc.0000000000000904
O'Brien WD Jr, Deng CX, Harris GR, et al. The risk of exposure to diagnostic ultrasound in postnatal subjects: thermal effects. J Ultrasound Med. 2008;27(4):517-535; quiz 537-540. doi:10.7863/jum.2008.27.4.517
Dynin M, Borhart J. What are the risks of doppler ultrasound in pregnancy? In: Graham A, Carlberg DJ, eds. Gastrointestinal Emergencies: Evidence-Based Answers to Key Clinical Questions. Springer International Publishing; 2019:371-372.
Radiology American College of Radiology (ACR). ACR Manual on Contrast Media. ACR; 2021.
Rofsky NM, Pizzarello DJ, Weinreb JC, Ambrosino MM, Rosenberg C. Effect on fetal mouse development of exposure to MR imaging and gadopentetate dimeglumine. J Magn Reson Imaging. 1994;4(6):805-807. doi:10.1002/jmri.1880040611
Chen MM, Coakley FV, Kaimal A, Laros RK Jr. Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation. Obstet Gynecol. 2008;112(2):333-340. doi:10.1097/aog.0b013e318180a505
Woitek R, Prayer D, Hojreh A, Helbich T. Radiological staging in pregnant patients with cancer. ESMO Open. 2016;1:e000017. doi:10.1136/esmoopen-2015-000017
American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice. Committee Opinion No. 656 Summary: guidelines for diagnostic imaging during pregnancy and lactation. Obstet Gynecol. 2016;127:e75-e80.
Gjelsteen AC, Ching BH, Meyermann MW, et al. CT, MRI, PET, PET/CT, and ultrasound in the evaluation of obstetric and gynecologic patients. Surg Clin North Am. 2008; 88:361-390, vii.
Begano D, Söderberg M, Bolejko A. To use or not use patient shielding on pregnant women undergoing CT pulmonary angiography: a phantom study. Radiat Prot Dosimetry. 2020;189(4):458-465. doi:10.1093/rpd/ncaa059
Patel SJ, Reede DL, Katz DS, Subramaniam R, Amorosa JK. Imaging the pregnant patient for nonobstetric conditions: algorithms and radiation dose considerations. Radiographics. 2007;27(6):1705-1722. doi:10.1148/rg.276075002
Sood R, Rositch AF, Shakoor D, et al. Ultrasound for breast cancer detection globally: a systematic review and meta-analysis. J Glob Oncol. 2019;5:1-17. doi:10.1200/jgo.19.00127
Wu LM, Hu J, Gu HY, Hua J, Xu JR. Can diffusion-weighted magnetic resonance imaging (DW-MRI) alone be used as a reliable sequence for the preoperative detection and characterisation of hepatic metastases? A meta-analysis. Eur J Cancer. 2013;49(3):572-584. doi:10.1016/j.ejca.2012.08.021
Hodby K, Fields PA. Management of lymphoma in pregnancy. Obstet Med. 2009;2:46-51. doi:10.1258/om.2009.090007
Petralia G, Padhani AR, Pricolo P, et al. Whole-body magnetic resonance imaging (WB-MRI) in oncology: recommendations and key uses. Radiol Med. 2019;124(3):218-233. doi:10.1007/s11547-018-0955-7
Park JJ, Kim CK, Park SY, Park BK. Parametrial invasion in cervical cancer: fused T2-weighted imaging and high-b-value diffusion-weighted imaging with background body signal suppression at 3 T. Radiology. 2015;274:734-741. doi:10.1148/radiol.14140920
Gui B, Cambi F, Micco M, et al. MRI in pregnant patients with suspected abdominal and pelvic cancer: a practical guide for radiologists. Diagn Interv Radiol. 2020;26:183-192.
Andreotti RF, Timmerman D, Strachowski LM, et al. O-RADS US risk stratification and management system: a consensus guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee. Radiology. 2020;294(1):168-185. doi:10.1148/radiol.2019191150
Thomassin-Naggara I, Poncelet E, Jalaguier-Coudray A, et al. Ovarian-Adnexal Reporting Data System Magnetic Resonance Imaging (O-RADS MRI) score for risk stratification of sonographically indeterminate adnexal masses. JAMA Netw Open. 2020;3(1):e1919896. doi:10.1001/jamanetworkopen.2019.19896
Michielsen K, Vergote I, Op de Beeck K, et al. Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT. Eur Radiol. 2014;24(4):889-901. doi:10.1007/s00330-013-3083-8
Amant F, Berveiller P, Boere IA, et al. Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting. Ann Oncol. 2019;30(10):1601-1612. doi:10.1093/annonc/mdz228
Niekel MC, Bipat S, Stoker J. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology. 2010;257(3):674-684. doi:10.1148/radiol.10100729
Taylor SA, Mallett S, Miles A, et al. Whole-body MRI compared with standard pathways for staging metastatic disease in lung and colorectal cancer: the Streamline diagnostic accuracy studies. Health Technol Assess. 2019;23(66):1-270. doi:10.3310/hta23660
Dresen RC, De Vuysere S, De Keyzer F, et al. Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases. Cancer Imaging. 2019;19:1. doi:10.1186/s40644-018-0187-z
Kauffmann RM, Chen SL. Workup and staging of malignant melanoma. Surg Clin North Am. 2014;94:963-972, vii.
Van Calsteren K, Heyns L, De Smet F, et al. Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol. 2010;28(4):683-689. doi:10.1200/jco.2009.23.2801
Wolters V, Heimovaara J, Maggen C, et al. Management of pregnancy in women with cancer. Int J Gynecol Cancer. 2021;31(3):314-322. doi:10.1136/ijgc-2020-001776
Pinnix CC, Osborne EM, Chihara D, et al. Maternal and fetal outcomes after therapy for Hodgkin or non-Hodgkin lymphoma diagnosed during pregnancy. JAMA Oncol. 2016;2(8):1065-1069. doi:10.1001/jamaoncol.2016.1396
Botha MH, Rajaram S, Karunaratne K. Cancer in pregnancy. Int J Gynaecol Obstet. 2018;143(suppl 2):137-142. doi:10.1002/ijgo.12621
Shaw P, Duncan A, Vouyouka A, Ozsvath K. Radiation exposure and pregnancy. J Vasc Surg. 2011;53(1 suppl):28S-34S. doi:10.1016/j.jvs.2010.05.140
Loibl S, Han SN, von Minckwitz G, et al. Treatment of breast cancer during pregnancy: an observational study. Lancet Oncol. 2012;13(9):887-896. doi:10.1016/s1470-2045(12)70261-9
Zagouri F, Sergentanis TN, Chrysikos D, Papadimitriou CA, Dimopoulos MA, Bartsch R. Trastuzumab administration during pregnancy: a systematic review and meta-analysis. Breast Cancer Res Treat. 2013;137(2):349-357. doi:10.1007/s10549-012-2368-y
Decker M, Rothermundt C, Holländer G, Tichelli A, Rochlitz C. Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy. Lancet Oncol. 2006;7(8):693-694. doi:10.1016/s1470-2045(06)70797-5
Schneider D, Heilmann L, Harenberg J. [Placental transfer of low-molecular weight heparin]. Geburtshilfe Frauenheilkd. 1995;55(02):93-98. doi:10.1055/s-2007-1022782
Sessa M, Mascolo A, Callréus T, Capuano A, Rossi F, Andersen M. Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®. Sci Rep. 2019;9(1):7236. doi:10.1038/s41598-019-43715-4
Vandenbroucke T, Verheecke M, Fumagalli M, Lok C, Amant F. Effects of cancer treatment during pregnancy on fetal and child development. Lancet Child Adolesc Health. 2017;1(4):302-310. doi:10.1016/s2352-4642(17)30091-3